Pharma Industry invest $1 billion to sustain antibiotic pipeline on the verge of collapse. For the past 30 years, antibiotic-resistant bacteria have dramatically increased while very few antibiotics were approved. Through AMR Action Fund 20+ top Pharma will invest in smaller biotech to support the development of novel antibiotics.
Comments